Effectiveness of Biologic Agents Among Hispanic Patients With Metastatic Colorectal Cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effectiveness of Biologic Agents Among Hispanic Patients With Metastatic Colorectal Cancer
Authors
Keywords
-
Journal
Clinical Colorectal Cancer
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-10-07
DOI
10.1016/j.clcc.2023.10.001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diversity, equity, and inclusion in genitourinary clinical trials leading to FDA novel drug approval: An assessment of the FDA center for drug evaluation and research drug trials snapshot
- (2023) Asia N. Matthew-Onabanjo et al. CURRENT PROBLEMS IN CANCER
- Institutional barriers to clinical trial exploration experienced by the Latinx community
- (2023) Sabrina Sandoval et al. JOURNAL OF CANCER EDUCATION
- Impact of race and ethnicity on presentation and outcomes of patients treated on rhabdomyosarcoma clinical trials: A report from the Children's Oncology Group
- (2023) Senna R. Munnikhuysen et al. Cancer Medicine
- Assessment of Racial/Ethnic Disparities in Timeliness and Comprehensiveness of Dementia Diagnosis in California
- (2021) Elena Tsoy et al. JAMA Neurology
- Cancer statistics for the US Hispanic/Latino population, 2021
- (2021) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Race and ethnicity representation in clinical trials: findings from a literature review of Phase I oncology trials
- (2021) D Ross Camidge et al. Future Oncology
- Comparative Effectiveness of Biologic Agents Among Black and White Medicare Patients in the US With Metastatic Colorectal Cancer
- (2021) Sanjay Goel et al. JAMA Network Open
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Programmed Cell Death Protein-1 (PD-1)-Targeted Immunotherapy for Advanced Hepatocellular Carcinoma in Real World
- (2020) Hanzhi Cui et al. OncoTargets and Therapy
- Trends in colorectal cancer mortality in hispanics: a SEER analysis
- (2017) Afsaneh Barzi et al. Oncotarget
- Metastatic Colorectal Cancer in Hispanics: Treatment Outcomes in a Treated Population
- (2016) Maryam Shabihkhani et al. Clinical Colorectal Cancer
- Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study
- (2015) Josep Tabernero et al. LANCET ONCOLOGY
- Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer
- (2015) Robert J. Mayer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
- (2014) Fotios Loupakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial
- (2013) David Cunningham et al. LANCET ONCOLOGY
- A Review of Cancer in U.S. Hispanic Populations
- (2012) R. W. Haile et al. Cancer Prevention Research
- Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
- (2012) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) Axel Grothey et al. LANCET
- Welcome to the Journal of Comparative Effectiveness Research
- (2012) Sheldon Greenfield et al. Journal of Comparative Effectiveness Research
- Trends in Colorectal Cancer Among Hispanics by Stage and Subsite Location: 1989–2006
- (2012) M N Hernandez et al. Clinical and Translational Gastroenterology
- Evolvement of the treatment paradigm for metastatic colon cancer. From chemotherapy to targeted therapy
- (2011) Santiago Aparo et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
- (2011) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Racial disparities in colorectal cancer survival
- (2010) Arica White et al. CANCER
- Hospital Factors and Racial Disparities in Mortality After Surgery for Breast and Colon Cancer
- (2009) Tara M. Breslin et al. JOURNAL OF CLINICAL ONCOLOGY
- The estimation of average hazard ratios by weighted Cox regression
- (2009) Michael Schemper et al. STATISTICS IN MEDICINE
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
- (2008) Leonard B. Saltz et al. JOURNAL OF CLINICAL ONCOLOGY
- Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
- (2008) Rafael G. Amado et al. JOURNAL OF CLINICAL ONCOLOGY
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immortal Time Bias in Pharmacoepidemiology
- (2007) S. Suissa AMERICAN JOURNAL OF EPIDEMIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now